ArticleFrontiers in pharmacology2022

CD44/Folate Dual Targeting Receptor Reductive Response PLGA-Based Micelles for Cancer Therapy.

Ru Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.